Does ATEZOLIZUMAB Cause Biliary tract infection? 22 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 22 reports of Biliary tract infection have been filed in association with ATEZOLIZUMAB (Tecentriq Hybreza). This represents 0.1% of all adverse event reports for ATEZOLIZUMAB.
22
Reports of Biliary tract infection with ATEZOLIZUMAB
0.1%
of all ATEZOLIZUMAB reports
6
Deaths
17
Hospitalizations
How Dangerous Is Biliary tract infection From ATEZOLIZUMAB?
Of the 22 reports, 6 (27.3%) resulted in death, 17 (77.3%) required hospitalization, and 3 (13.6%) were considered life-threatening.
Is Biliary tract infection Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ATEZOLIZUMAB. However, 22 reports have been filed with the FAERS database.
What Other Side Effects Does ATEZOLIZUMAB Cause?
Death (3,591)
Off label use (2,340)
Disease progression (1,828)
Pyrexia (1,599)
Diarrhoea (1,490)
Fatigue (1,253)
Anaemia (1,195)
Pneumonia (1,036)
Nausea (953)
Dyspnoea (938)
What Other Drugs Cause Biliary tract infection?
PACLITAXEL (105)
GEMCITABINE (92)
DURVALUMAB (72)
TREMELIMUMAB (58)
OXALIPLATIN (39)
FLUOROURACIL (32)
NIVOLUMAB (29)
LEUCOVORIN (24)
IRINOTECAN (23)
BEVACIZUMAB (19)
Which ATEZOLIZUMAB Alternatives Have Lower Biliary tract infection Risk?
ATEZOLIZUMAB vs ATLANTIC SALMON OIL
ATEZOLIZUMAB vs ATOGEPANT
ATEZOLIZUMAB vs ATOMOXETINE
ATEZOLIZUMAB vs ATOMOXETINE\ATOMOXETINE
ATEZOLIZUMAB vs ATORVASTATIN